Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. ESMO Congress 2024
  5. Satellite Symposia Webcasts

Novartis - Preparing for the future: Radioligand therapy as an essential pillar in oncology

Panelists’ insights - Multi-stakeholder Perspectives on Overcoming Barriers to Establishing RLT in Oncology

Date

14 Sep 2024

Session

Novartis - Preparing for the future: Radioligand therapy as an essential pillar in oncology

Topics

Nuclear Medicine and Clinical Molecular Imaging;  Multi-Disciplinary and Multi-Professional Cancer Care;  Cancer Care Equity Principles and Health Economics

Tumour Site

Neuroendocrine Neoplasms;  Prostate Cancer

Presenters

Leonhard Schätz, Ken Herrmann, Erik Briers, Elena Castro, Désirée Deandreis

Authors

L. Schätz1, K. Herrmann2, E.A. Briers3, E. Castro4, D. Deandreis5

Author affiliations

  • 1 Health System & Partnership, Novartis Campus Basel, 4056 - Basel/CH
  • 2 Nuclear Medicine Department, WTZ - Westdeutsches Tumorzentrum Essen, 45147 - Essen/DE
  • 3 Liaison Officer, Europa Uomo - The European Prostate Cancer Coalition, 2018 - Antwerpen/BE
  • 4 Medical Oncology Dept., Hospital Universitario 12 de Octubre, 28041 - Madrid/ES
  • 5 Nuclear Medicine, Institut Gustave Roussy, 94805 - Villejuif, Cedex/FR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Open Forum: Q&A Session

Presenter: Leonhard Schätz, Ken Herrmann, Erik Briers, Elena Castro, Désirée Deandreis

Session: Novartis - Preparing for the future: Radioligand therapy as an essential pillar in oncology

Resources:

Webcast

Closing Session: Final Thoughts

Presenter: Leonhard Schätz, Ken Herrmann, Erik Briers, Elena Castro, Désirée Deandreis

Session: Novartis - Preparing for the future: Radioligand therapy as an essential pillar in oncology

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.